AllianceBernstein’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

AllianceBernstein’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-191,320	Closed	-$484K	–	3219
2023 Q4	$484K	Hold	191,320	–	–	﹤0.01%	2622
2023 Q3	$457K	Hold	191,320	–	–	﹤0.01%	2615
2023 Q2	$442K	Buy	191,320 +32,820	+21%	+$92.7K	﹤0.01%	2702
2023 Q1	$404K	Hold	158,500	–	–	﹤0.01%	2657
2022 Q4	$398K	Buy	158,500 +11,100	+8%	+$31K	﹤0.01%	2750
2022 Q3	$427K	Hold	147,400	–	–	﹤0.01%	2721
2022 Q2	$666K	Buy	+147,400	New	+$877K	﹤0.01%	2546

AllianceBernstein's SLGC Position: Q1 2024 in Review

AllianceBernstein sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 191,320 shares — an estimated $484K sold.

AllianceBernstein first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $666K in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

AllianceBernstein reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
AllianceBernstein sold 191,320 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $484K.
AllianceBernstein first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
AllianceBernstein's SomaLogic, Inc. Class A Common Stock position peaked at $666K in Q2 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on AllianceBernstein's 13F filing for Q1 2024, filed 14 May 2024.